BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

641 related articles for article (PubMed ID: 19072422)

  • 21. [Epidemiology of Clostridium difficile infection].
    Szczesny A; Martirosian G
    Przegl Epidemiol; 2002; 56(1):49-56. PubMed ID: 12150067
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Clostridium difficile-associated diarrhea and chronic renal insufficiency.
    Yousuf K; Saklayen MG; Markert RJ; Barde CJ; Gopalswamy N
    South Med J; 2002 Jul; 95(7):681-3. PubMed ID: 12144071
    [TBL] [Abstract][Full Text] [Related]  

  • 23. What have we learned about antimicrobial use and the risks for Clostridium difficile-associated diarrhoea?
    Blondeau JM
    J Antimicrob Chemother; 2009 Feb; 63(2):238-42. PubMed ID: 19028718
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Life-threatening infections with a new strain of Clostridium difficile].
    Krausz S; Bessems M; Boermeester MA; Kuijper EJ; Visser CE; Speelman P
    Ned Tijdschr Geneeskd; 2005 Sep; 149(38):2081-6. PubMed ID: 16201595
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Recent advances in Clostridium difficile-associated disease.
    Monaghan T; Boswell T; Mahida YR
    Postgrad Med J; 2009 Mar; 85(1001):152-62. PubMed ID: 19351643
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Clostridium-difficile-associated diarrhea].
    Bujanda L; Cosme A
    Gastroenterol Hepatol; 2009 Jan; 32(1):48-56. PubMed ID: 19174100
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Emergence of fluoroquinolones as the predominant risk factor for Clostridium difficile-associated diarrhea: a cohort study during an epidemic in Quebec.
    Pépin J; Saheb N; Coulombe MA; Alary ME; Corriveau MP; Authier S; Leblanc M; Rivard G; Bettez M; Primeau V; Nguyen M; Jacob CE; Lanthier L
    Clin Infect Dis; 2005 Nov; 41(9):1254-60. PubMed ID: 16206099
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Treatment of infections associated with Clostridium difficile].
    Szczesny A; Martirosian G
    Wiad Lek; 2003; 56(5-6):278-82. PubMed ID: 14526488
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Prevalence and clinical features of Clostridium difficile-associated diarrhea in a tertiary hospital in northern Taiwan.
    Hsu MS; Wang JT; Huang WK; Liu YC; Chang SC
    J Microbiol Immunol Infect; 2006 Jun; 39(3):242-8. PubMed ID: 16783456
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Epidemiology, risk factors and prevention of Clostridium difficile nosocomial infections].
    Barbut F; Petit JC
    Pathol Biol (Paris); 2000 Oct; 48(8):745-55. PubMed ID: 11244603
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The challenges posed by reemerging Clostridium difficile infection.
    Blossom DB; McDonald LC
    Clin Infect Dis; 2007 Jul; 45(2):222-7. PubMed ID: 17578783
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The use of probiotics in the prevention and treatment of antibiotic-associated diarrhea with special interest in Clostridium difficile-associated diarrhea.
    Rohde CL; Bartolini V; Jones N
    Nutr Clin Pract; 2009; 24(1):33-40. PubMed ID: 19244146
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Impact of a reduction in the use of high-risk antibiotics on the course of an epidemic of Clostridium difficile-associated disease caused by the hypervirulent NAP1/027 strain.
    Valiquette L; Cossette B; Garant MP; Diab H; Pépin J
    Clin Infect Dis; 2007 Sep; 45 Suppl 2():S112-21. PubMed ID: 17683015
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Epidemiology, clinical manifestations, and outcome of Clostridium difficile-associated diarrhea.
    Anand A; Bashey B; Mir T; Glatt AE
    Am J Gastroenterol; 1994 Apr; 89(4):519-23. PubMed ID: 8147353
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [The approach to recurrent infections with Clostridium difficile].
    Paz Z; Altman A
    Harefuah; 2008 Nov; 147(11):864-5, 942. PubMed ID: 19264004
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Epidemiology of Clostridium difficile-associated diarrhea in a Peruvian tertiary care hospital.
    Garcia C; Samalvides F; Vidal M; Gotuzzo E; Dupont HL
    Am J Trop Med Hyg; 2007 Nov; 77(5):802-5. PubMed ID: 17984329
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Management and outcomes of a first recurrence of Clostridium difficile-associated disease in Quebec, Canada.
    Pépin J; Routhier S; Gagnon S; Brazeau I
    Clin Infect Dis; 2006 Mar; 42(6):758-64. PubMed ID: 16477549
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Clostridium difficile-associated diarrhoea.
    Elliott B; Chang BJ; Golledge CL; Riley TV
    Intern Med J; 2007 Aug; 37(8):561-8. PubMed ID: 17640189
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Antibiotic-induced diarrhea: recent findings about Clostridium difficile].
    Cervetto JL
    Acta Gastroenterol Latinoam; 1996; 26(4):251-4. PubMed ID: 9335932
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Occurrence and treatment of Clostridium difficile-associated diarrhea].
    Tvede M; Høiby N
    Ugeskr Laeger; 2006 Jun; 168(26-32):2579; author reply 2579-80. PubMed ID: 16824400
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 33.